247 related articles for article (PubMed ID: 12351601)
1. Tyrosinase mRNA in blood of patients with melanoma treated with adjuvant interferon.
Mellado B; Del Carmen Vela M; Colomer D; Gutierrez L; Castel T; Quintó L; Fontanillas M; Reguart N; Domingo-Domènech JM; Montagut C; Estapé J; Gascón P
J Clin Oncol; 2002 Oct; 20(19):4032-9. PubMed ID: 12351601
[TBL] [Abstract][Full Text] [Related]
2. Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCR.
Domingo-Domènech J; Molina R; Castel T; Montagut C; Puig S; Conill C; Martí R; Vera M; Auge JM; Malvehy J; Grau JJ; Gascon P; Mellado B
Oncology; 2005; 68(4-6):341-9. PubMed ID: 16020961
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon.
Gogas H; Kefala G; Bafaloukos D; Frangia K; Polyzos A; Pectasides D; Tsoutsos D; Panagiotou P; Ioannovich J; Loukopoulos D
Br J Cancer; 2002 Jul; 87(2):181-6. PubMed ID: 12107840
[TBL] [Abstract][Full Text] [Related]
4. Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).
Fusi A; Collette S; Busse A; Suciu S; Rietz A; Santinami M; Kruit WH; Testori A; Punt CJ; Dalgleish AG; Spatz A; Eggermont AM; Keilholz U
Eur J Cancer; 2009 Dec; 45(18):3189-97. PubMed ID: 19793643
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
[TBL] [Abstract][Full Text] [Related]
6. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Wang HJ; Elashoff RM; Takeuchi H; Umetani N; Hoon DS
J Clin Oncol; 2005 Nov; 23(31):8057-64. PubMed ID: 16258104
[TBL] [Abstract][Full Text] [Related]
7. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
8. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma.
Schmidt H; Sørensen BS; von der Maase H; Bang C; Agger R; Hokland M; Nexo E
Melanoma Res; 2002 Dec; 12(6):585-92. PubMed ID: 12459648
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic importance of reverse-transcriptase polymerase chain reaction detection of circulating messenger RNA in patients with melanoma.
Ranieri JM; Wagner JD; Wiebke EA; Azuaje R; Smith ML; Wenck S; Daggy J; Coleman JJ
Plast Reconstr Surg; 2005 Apr; 115(4):1058-63. PubMed ID: 15793446
[TBL] [Abstract][Full Text] [Related]
11. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
[TBL] [Abstract][Full Text] [Related]
13. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
[TBL] [Abstract][Full Text] [Related]
14. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.
Farthmann B; Eberle J; Krasagakis K; Gstöttner M; Wang N; Bisson S; Orfanos CE
J Invest Dermatol; 1998 Mar; 110(3):263-7. PubMed ID: 9506446
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.
Mellado B; Gutierrez L; Castel T; Colomer D; Fontanillas M; Castro J; Estapé J
Clin Cancer Res; 1999 Jul; 5(7):1843-8. PubMed ID: 10430090
[TBL] [Abstract][Full Text] [Related]
16. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
Glumac N; Snoj M; Hocevar M; Novakovic S
Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
[TBL] [Abstract][Full Text] [Related]
19. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
[TBL] [Abstract][Full Text] [Related]
20. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
